Cantitate/Preț
Produs
Total produse
Vezi coșul
The End of Alzheimer's de Dale Bredesen

The End of Alzheimer's

Autor Dale Bredesen
en Limba Engleză Paperback – 21 aug 2017
Rewriting the science of Alzheimer's Disease, this book presents the first proven plan to reverse Alzheimer's Disease. Revealing that AD is not one condition but in fact three, it outlines 36 metabolic factors, including micronutrients, hormone levels and sleep, which together can trigger downsizing in the brain.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (2) 8647 lei  24-35 zile +3314 lei  7-11 zile
  Ebury Publishing – 21 aug 2017 8647 lei  24-35 zile +3314 lei  7-11 zile
  Penguin Publishing Group – 20 iul 2020 10077 lei  6-8 săpt. +1941 lei  7-11 zile
Hardback (1) 14375 lei  3-5 săpt.
  Penguin Publishing Group – 22 aug 2017 14375 lei  3-5 săpt.

Preț: 8647 lei

Preț vechi: 10853 lei
-20% Nou

Puncte Express: 130
Preț estimativ în valută:
1655€ • 1741$ • 1370£

Carte disponibilă

Livrare economică 27 decembrie 24 - 07 ianuarie 25
Livrare express 10-14 decembrie pentru 4313 lei

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781785041228
ISBN-10: 1785041223
Pagini: 320
Dimensiuni: 151 x 233 x 27 mm
Greutate: 0.42 kg
Editura: Ebury Publishing

Notă biografică

Dale Bredesen, MD, is internationally recognised as an expert in the mechanisms of neurodegenerative diseases, such as Alzheimer's disease. He graduated from Caltech, then earned his MD from Duke University Medical Center in Durham, North Carolina. He served as chief resident in neurology at the University of California, San Francisco (UCSF) before joining Nobel laureate Stanley Prusiner's laboratory at UCSF as an NIH postdoctoral fellow. He held faculty positions at UCSF, UCLA and the University of California, San Diego. Dr Bredesen directed the Program on Aging at the Burnham Institute before joining the Buck Institute in 1998 as its founding president and CEO. He is Professor of Neurology at the University of California, Los Angeles.